Partnership for Part D Access
  • Home
  • About Us
    • Who We Are
    • Patient Communities
    • Our Leadership
  • The Issue
    • Six Protected Classes
    • History
  • Resources
  • Newsroom
  • Stakeholder Voices
  • Contact Us
  • Home
  • About Us
    • Who We Are
    • Patient Communities
    • Our Leadership
  • The Issue
    • Six Protected Classes
    • History
  • Resources
  • Newsroom
  • Stakeholder Voices
  • Contact Us

Newsroom​ 

Partnership Applauds House Appropriations Committee for Report Expressing Concerns on ‘Six Protected Classes’

5/7/2019

0 Comments

 
Picture
FOR IMMEDIATE RELEASE
May 7, 2019 
Contact: Shea McCarthy 
smccarthy@thornrun.com 
(202) 285-3866

Washington D.C. — The Partnership for Part D Access, a broad-based coalition of health care stakeholders including over 20 diverse patient advocacy organizations, applauded the House Appropriations Committee for their report on the fiscal year (FY) 2020 Labor-HHS-Education spending measure, which raises concerns with a proposal from the Centers for Medicare and Medicaid Services (CMS) to weaken Medicare’s six protected classes policy. 
​As detailed on pg. 134, the Committee report specifically states the following:  

Protected Classes.—The Committee is concerned by the recent proposed rule, ‘‘Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses.’’ Shortly after Congress enacted the Medicare Part D program, CMS required all Part D plans to have adequate coverage for six therapeutic categories of drugs, known as protected classes, to ensure patients have timely access to critical therapies combating HIV, cancer, mental health conditions, and other serious illnesses. The provisions of this proposed rule would allow increased use of prior authorizations and step therapy requirements and potentially delay access to these therapies.

“The Partnership applauds Subcommittee Chairwoman Rosa DeLauro and Full Committee Chairwoman Nita Lowey on their commitment to protecting Medicare’s most vulnerable beneficiaries,” said Chuck Ingoglia, Sr. Vice President of Public Policy and Practice Improvement at the National Council for Behavioral Health, who serves as Executive Director of the Partnership. “For many patients with complex and hard-to-treat conditions, it can be dangerous and expensive to disrupt an effective regimen of prescription medications. We look forward to working with the Committee to ensure that patients with the most complicated conditions have access to the medicines that work best for them.”
0 Comments



Leave a Reply.

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    September 2022
    November 2021
    March 2021
    February 2021
    January 2021
    November 2020
    January 2020
    July 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    April 2018
    March 2018
    September 2017
    May 2017
    April 2017
    November 2016
    July 2016

    Categories

    All

    RSS Feed

Learn more

About Us
Patient Communities
​Issues
​Background

What's New?

​Newsroom
Resources
​

Contact

Contact Us
© COPYRIGHT 2018. ALL RIGHTS RESERVED.